Clearmind Medicine and SciSparc Collaboration Yields Another Patent Application for Cocaine ...
bdtonline.com
news
2022-06-02 11:51:13

No dedicated treatment currently available for cocaine addictionVANCOUVER, June 02, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) ('Clearmind' or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced it has filed a provisional patent application related to cocaine addiction.The move results from the company's recently launched collaboration with SciSparc Ltd.
